Currently viewing: Key risks and opportunities / Next: Material matters

Key risks and opportunities


We face many risks and opportunities in our day-to-day operations. We carefully manage these risks and capitalise on related opportunities to ensure our business remains sustainable and profitable. We discuss our risk management process below, which shows the importance of our employees' and patients' safety during an unprecedented period of time.

RISK MANAGEMENT PROCESS

Our risk management processes are fundamental to our business, and align with our core values and strategic focus areas. The Board is ultimately responsible for governing enterprise risk management, and ensuring that effective and robust enterprise risk management framework and processes are in place. The Board risk, compliance and IT governance committee (RCITComm) and the Group risk management function support and assist the Board.

Our combined assurance process has three lines of defence to ensure accountability and distinguish between risk oversight, owning and managing risks, and providing independent assurance. The RCITComm receives periodic, independent assurance on the effectiveness of our risk management processes from Internal Audit. Risks and opportunities are appropriately identified, assessed, evaluated and managed as part of our best practices. This is done by implementing an enterprise risk management strategy and framework that considers King IV's principles, and is based on the ISO 31000 international standards on risk management. Risks are also monitored according to their nature, potential impact and likelihood.

We embed risk management processes into our everyday operations to help us identify any events with potential to affect our ability to create value and to manage risks in line with our strategy effectively. Our line managers and employees ensure that the risk management framework and processes are implemented across the Group. The Group Risk Manager engages with key executives and senior management across the Group to identify risks relevant to both our southern Africa and international operations, which are then recorded in the Group risk register.

The Board and the RCITComm confirm they are satisfied that adequate, ongoing risk management processes are in place to provide reasonable assurance that key risks and opportunities are identified, evaluated and managed across the Group.

The key risks and opportunities we are exposed to are discussed below. This section can be read together with our material matters section.

1

FUNDER RISK

(2019 ranking: 1)

Risk description and context

Life Healthcare is under continuous pricing pressure from healthcare funders in southern Africa looking to manage the overall cost of healthcare. This is primarily driven by a challenging economic environment compounded by COVID-19, which placed pressure on these funders to contain increases in member contributions in an environment where the number of medically insured lives is declining. In response to this, and coupled with escalations in healthcare costs and utilisation, funders instituted managed care initiatives, more affordable plans but with less cover, stringent case management and increased restricted provider networks. There is also the possibility that an increasing number of patients will buy down their medical insurance scheme cover to network options with lower tariffs given the poor economic conditions. Our admission rates could be impacted by our ability to secure preferred network agreements with healthcare funders, and more stringent case management.

Alliance Medical operates across several markets that provide a portfolio of healthcare services. Funding challenges remain prevalent across all the UK and northern European health economies. Alliance Medical has a mix of public and private income streams. Public revenue comprises 90% of total revenue in the UK, 63% in Italy and 41% in Ireland.

Scanmed relies on servicing Poland's National Healthcare Fund, Narodowy Fundusz Zdrowia (NFZ), for a significant 81% portion of its revenue. It has limited diversification in its revenue sources, which places its revenue at risk when the NFZ applies pressure.

Potential opportunities

  • Through increased engagement, targeted interventions and a differentiated service offering, we can position ourselves as the local and international service provider of choice.

How we address this risk

  • Delivering excellent quality and cost effective care
  • Implemented an appropriate pricing strategy focusing on efficiencies and input costs
  • Focused on safeguarding good relationships with healthcare funders and engaging with them on their issues and concerns
  • Provided a differentiated service offering
  • Focused on interventions with doctors to increase clinical outcome data and efficiency
  • Managed long-term contracts with our international businesses and their national healthcare funds
  • Executed a strategy to include growth in private sector volumes

Stakeholders impacted

Shareholders, investors and financiers

Patients

Doctors and specialists

Government

Healthcare funders

Employees

Suppliers

Related material matters and assurance

  • Healthcare funders
  • Cost of care
  • Quality of care standards
  • Portfolio performance

3

2

1



2

SKILLED HEALTHCARE PROFESSIONAL SHORTAGES

(2019 ranking: 3)

Risk description and context

There is a general shortage of doctors in the South African and Polish healthcare markets, and a shortage of radiologists and radiographers in the regions where Alliance Medical operates. These shortages affect the Group's growth prospects, our ability to deliver quality care and services and, ultimately, our operations' sustainability.

The general shortage of healthcare professionals was exacerbated by COVID-19 during the year. Contributing factors include imposed movement restrictions in international countries and fear-related absenteeism, as well as healthcare professionals' illness after contracting COVID-19 or healthcare professionals being quarantined or isolated.

Potential opportunities

  • Assisting to alleviate critical skills shortages through our interventions and position Life Healthcare as a business supporting our associated healthcare professionals.

How we address this risk

  • A transparent recruitment and retention strategy exists that includes:
    • providing bursaries and sponsorship programmes to specialists, and facilitating continuous professional development training for them
    • ongoing engagement
    • a doctor partnership model and support policy, with regional clinical managers appointed to enhance doctor relationships and implement quality improvement initiatives
    • ensuring infrastructure and equipment at facilities are improved
    • enabling reduced professional indemnity premiums through enhanced clinical measures
  • Invested in various reward, development, recruitment and cultural initiatives to alleviate Alliance Medical's skills shortages
  • Operating the Life College of Learning - a higher education institution offering one of the top three private nursing qualifications in the country
  • Developing and retaining scarce pharmaceutical skills through online continuing professional education (CPE) modules and through our pharmacists' internship and pharmacists' assistant programmes
  • Hosted internships in Poland for selected and identified specialists to secure their ongoing services, along with vocational practices and apprenticeships
  • Constituted a dedicated workstream and hospital-based committees to address the impact of COVID-19, focusing on doctor availability and recruitment
  • Instituted tele-reporting in our international business, sourcing additional reporting capacity from other third-party houses
  • Supplied appropriate PPE to doctors and frontline employees, and instituted strict screening processes and protocols to manage infection risk

Stakeholders impacted

Doctors and specialists

Patients

Employees

Healthcare funders

Related material matters and assurance

  • COVID-19
  • Specialised skills shortage

2

1



3

CYBER-CRIME AND DATA BREACH

(2019 ranking: 5)

Risk description and context

The threat of cyber-security continues to be a key risk to our business globally. Criminal elements exploit the rapid and widespread adoption of work-from-home tools in light of COVID-19 to launch wide scale cyber-attacks. Remote working is the new norm and, as a result, extra vigilance and cyber-crime awareness is required around data security profiles and the accessibility of data. The balance between securing data behind a firewall and making it readily accessible to employees and business partners has to shift to support new working ways of working while keeping existing business processes and operations moving.

Our southern African business was a victim of a cyberattack during the year. For more information, refer to Cyber-incident

Potential opportunities

  • Investing in information security controls to enhance our existing security measures and safeguard our data to provide reassurance to our stakeholders.

How we address this risk

  • Continued implementation of a mature information security management system (ISMS) internationally certified by the British Standards Institution (BSI) (ISO 27001:2003)
  • Performed regular risk assessments, including annual internal and external security assessments
  • Implemented an information management strategy to improve security and manage residual risks, along with further measures to protect the Group's intellectual property from hacking and other illegal cyber-activities
  • Ongoing implementation of logical and physical IT security controls, including advanced email protection, firewalls, end-point protection, cyber-security enhancements and personal information protection
  • Implemented proactive tools to detect and respond to cyber-threats
  • Regularly provided information security and cyber-awareness training for employees
  • Monitored security events through our 24/7 security operations centre (SOC)
  • Ensured adherence with the requirements of the General Data Protection Regulation (GDPR)

Stakeholders impacted

Patients

Employees

Suppliers

Related material matters and assurance

  • Cost of care
  • Increasing regulations

3

2

1



4

HUMAN CAPITAL (PEOPLE) RISK

(2019 ranking: 6)

Risk description and context

People are our most important asset and are key to our ongoing success.

The healthcare sector has experienced a general shortage of nursing employees across all categories of nursing with increasing shortages in specialist registered nursing personnel. These shortages were further impacted by COVID-19 over the year. Some contributing factors included:

  • Increased infection rates in nursing personnel and frontline employees caring for COVID-19 positive patients requiring employees to go into quarantine or isolation
  • Increased demand for nursing skills in the South African public sector in light of the drive to supply resources to public facilities and field hospitals
  • Increased demand for additional nursing personnel under COVID-19 surge conditions to treat the influx of COVID-19 positive patients at facilities

Due to the highly specialised nature of the healthcare industry and in light of key growth strategies, certain executive and management employees have a significant impact on the Group's performance. Failure to attract and to retain employees with the appropriate skillsets for these key roles could hamper performance and ultimately achievement of objectives.

As a responsible employer, we are required to provide a safe work environment for all our employees. At the same time, we need to provide care to our patients and fulfil all essential service provider responsibilities.

Potential opportunities

  • Through targeted succession planning, we ensure business continuity and are able to attract talented leaders
  • Quality human resources improve business performance

How we address this risk

  • Effective sourcing strategies and recruitment campaigns
  • Ongoing review of senior management resources and succession plans in place for key positions
  • Enhanced employee value propositions, including employee share schemes, remuneration and other benefits to attract and retain employees
  • Management and leadership development programmes in place
  • Clear career path for employees and continuous training and development programmes
  • Arrangements are in place with Agencies to provide agency employees in need
  • Redeployment strategy in place for the utilisation of nursing employees from other units and regions in the event of shortages
  • A number of infection prevention protocols were instituted and training provided to safeguard and protect employees from exposure to COVID-19
  • Employees were provided with guidelines and training on the appropriate and correct use of PPE
  • Employees were supplied with adequate PPE
  • Remote working capabilities were effected for non-essential employees capable of working offsite
  • Designated COVID-19 Compliance Officers were appointed to oversee implementation of the return-to-work plan and adherence to the standards of hygiene and health protocols related to COVID-19 at the workplace

Stakeholders impacted

Employees

Related material matters and assurance

  • Specialised skills shortage
  • Labour relations and employee retention

3

2

1



5

COMPLEXITY OF REGULATORY AND COMPLIANCE RISK

(2019 ranking: 2)

Risk description and context

The Group is required to comply with all applicable laws and regulations of the countries where we operate. In addition to these general compliance requirements, the global healthcare industry is subject to a growing number of new regulations.

A myriad of laws are being amended or promulgated in South Africa due to COVID-19, with which we are required to keep abreast of and comply with. Regulations issued in terms of the Disaster Management Act, 57 of 2002 (DMA) required that a COVID-19 Compliance Officer be appointed to oversee the implementation of a return-to-work plan and ensure adherence to the standards of hygiene and health protocols relating to COVID-19 at the workplace.

The Protection of Personal Information Act, 4 of 2013 (POPIA) was promulgated as of 1 July 2020, allowing for a one-year transition period for compliance. The National Health Insurance (NHI) Bill, the Medical Schemes Amendment Bill and the Office of Healthcare Standards: Norms and Standards introduced by the Department of Health (DOH) continue to require our attention.

Internationally, we remain committed to adhering to the GDPR, which applies to the European Union (EU) and the European Economic Area (EEA).

Potential opportunities

  • Assisting the industry in developing appropriate solutions through continued engagement with regulators and relevant bodies.
  • Enhancing and protecting our reputation through ongoing compliance with laws and regulations.
  • Transparent engagement processes could potentially enhance our relationships with a variety of stakeholders, including regulatory bodies.

How we address this risk

  • Proactively monitored and, where possible, provided input for any new proposed legislation, considering the interest of all stakeholders in each respective territory
  • Ensured compliance through our quality standards
  • Appointed COVID-19 Compliance Officers in our southern Africa business, and instituted a COVID-19 compliance forum
  • Consulted with legal, and health and safety experts to ensure compliance with DMA requirements
  • Appointed a Group Privacy Officer, and in the process of developing an action plan to ensure full compliance with POPIA requirements
  • Developed a privacy policy and standard operating procedures to guide our business
  • Conducted training on GDPR and POPIA requirements
  • Updated and designed processes to accommodate GDPR requirements

Stakeholders impacted

Shareholders, investors and financiers

Patients

Doctors and specialists

Government

Healthcare funders

Employees

Suppliers

Industry and regulatory bodies

Related material matters and assurance

  • Cost of care
  • Increasing regulations
  • Quality of care standards
  • Government relationships

3

2

1



6

MACROECONOMIC AND GEOPOLITICAL RISK

(2019 ranking: 4)

Risk description and context

We operate in the global healthcare market, and our operations are spread across different countries. The risk exists that country-specific factors, such as economic and political factors, or government policies, could adversely affect the Group.

Economies worldwide are staggering under the devastating effects of government-imposed lockdowns and social distancing measures to combat the spread of COVID-19. A deep global economic recession could become a reality, which could further exacerbate the current economic conditions in South Africa, impacting the affordability of healthcare.

We also potentially face the implications of a no deal or disruptive Brexit.

Potential opportunities

  • Building relationships based on trust by actively working with local governments, thereby positively impacting the healthcare markets in the countries where we operate.

How we address this risk

  • Actively monitored country-specific factors in the countries where we operate
  • Ongoing engagements with regulators and governments
  • Executed Brexit contingency and continuity planning
  • Divested interest where appropriate

Stakeholders impacted

Shareholders, investors and financiers

Government

Healthcare funders

Related material matters and assurance

  • Healthcare funders
  • Government relationships
  • COVID-19
  • Portfolio performance

2

1



7

CLINICAL AND PATIENT SAFETY RISK

(2019 ranking: 7)

Risk description and context

The quality of healthcare services provided by the Group and healthcare professionals and our patients' safety is of utmost importance to us. Failure to consistently deliver safe, high-quality care to our patients is a risk.

Excessive demand arising from a surge in Covid-19 admissions and the resultant employee shortages and capacity constraints could negatively impact on the quality of care at facilities.

We are exposed to the potential risk of medical professionals not meeting their professional obligations in treating patients by following an incorrect or inadequate clinical protocol. This is because no specific treatment is available for COVID-19, and existing treatment is supportive.

With the highly contagious nature of Covid-19 there is the potential risk of a large-scale outbreak at one or multiple of our facilities. No large scale outbreaks were evident over the financial year particularly during the peak of Covid-19 infections.

Potential opportunities

  • Enhancing the patient experience and protecting our reputation through an ongoing focus on quality and safety.
  • Improving patient care and safety according to industry best practice through continuous, robust engagements with health authorities and specialists.

How we address this risk

  • Implemented a quality management system (QMS) to ensure we provide quality healthcare, and established quality control procedures
  • Acquired QMS certification, and we are ISO 9001 and ISO 13485 accredited through BSI
  • Monitored clinical performance indicators
  • Held quarterly national quality review meetings
  • Carried out internal quality assessments at each hospital by the quality systems support specialist (QSSS)
  • Medical malpractice and professional indemnity insurance is in place
  • Regularly trained employees on quality procedures
  • Established a dedicated doctor work stream, and constituted doctor COVID-19 committees and ethics sub-committees at hospitals to ensure correct clinical protocols are followed and ensure doctor supply
  • Implemented various resourcing strategies, such as leveraging agency employees to meet increased demand or to stand in for infected employees, redeploying existing employees from other wards and postponing or cancelling leave
  • Through a capacity workstream, managed the sourcing of additional ventilators and other equipment required for treatment
  • Conducted independent verification reviews at facilities to review COVID-19 treatment readiness plans and ensure alignment with Group protocols
  • Instituted the standard practice of temporary capacity diverts (TCDs) at facilities to ensure the best possible options or patients based on their acuity level
  • Implemented various measures and guidelines to curb the spread of COVID-19 at our facilities, including infection prevention protocols, screening protocols, and guidelines for using PPE

Stakeholders impacted

Patients

Healthcare funders

Doctors and specialists

Shareholders, investors and financiers

Industry and regulatory bodies

Related material matters and assurance

  • COVID-19
  • Quality of care standards

3

2

1



8

IT INFRASTRUCTURE,
DISASTER RECOVERY AND PROJECT IMPLEMENTATION

(2019 ranking: 8)

Risk description and context

Information and information exchange are crucial to the delivery of care on all levels of the health care delivery system - the patient, healthcare funding providers, the Life Healthcare and management teams and healthcare regulators. There is a drive towards electronic health records and digitisation as healthcare becomes more consumer-friendly. Therefore, our IT infrastructure and systems must be appropriate and fit-for-purpose to respond to this cultural shift.

There is also a risk of failure to maintain reliable information systems for business operations in the event of an IT disaster like a data breach.

We are exposed to implementation risk regarding information management projects underway to improve existing infrastructure and ensure better Group-wide integration.

Potential opportunities

  • Offer better and more efficient services to our patients by investing in our IT infrastructure, thereby lowering the cost of care while maintaining quality.
  • Appropriate and effective IT infrastructure and systems are in place to support growth initiatives and performance expectations, allowing us the opportunity to be more competitive.

How we address this risk

  • Conducted regular, periodic assessments of our IT infrastructure, and implemented action plans to effect enhancements and address shortcomings
  • Maintained disaster recovery capabilities
  • Annually perform disaster recovery tests, with action plans documented and implemented to address any identified shortcomings
  • Followed rigorous project management methodology, with strong business sponsor leadership and oversight
  • A formal systems development lifecycle (SDLC) process is in place and a total cost of ownership (TCO) costing model is applied to each project
  • Conducted project prioritisation
  • Maintained risk registers for projects, with a response plan in place for identified risks

Stakeholders impacted

Patients

Doctors and specialists

Government

Employees

Suppliers

Healthcare funders

Related material matters and assurance

  • Cost of care

3

2

1



9

REPUTATIONAL RISK

(2019 ranking: 9)

Risk description and context

The Group's reputation and relationships with key stakeholders could be affected by adverse events that occur while healthcare professionals perform clinical procedures or other related activities.

Furthermore, events outside of our control can adversely affect our brand.

Potential opportunities

  • Enhancing and protecting our reputation through an ongoing focus on quality and a clear communication strategy.

How we address this risk

  • Implementing quality management processes across the business, with ISO 9001 certification held
  • Dedicated media strategy in place for dealing with complaints raised through the media and other media-related issues

Stakeholders impacted

Industry and regulatory bodies

Shareholders, investors and financiers

Healthcare funders

Doctors and specialists

Related material matters and assurance

  • Increasing regulations
  • Quality of care standards

3

2

1